Table 2.
Number of patients with at least one lab test performed and claimed among 703,484 initiators of statins and/or ezetimibe using 6, 9, and 12-month confounder assessment periods (CAPs)
| All patients |
Number (%) of patients with at least 1 lab test performed* |
Number (%) of patients with at least 1 LDL lab test performed |
Number (%) of patients with at least 1 LDL lab test performed |
||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
6 month CAP |
9 month CAP |
12 month CAP |
6 month CAP |
9 month CAP |
12 month CAP |
6 month CAP |
9 month CAP |
12 month CAP |
|||||||||||
| N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | N | % | ||
| All patients |
703,484 |
481,133 |
68% |
505,161 |
72% |
520,559 |
74% |
421,708 |
60% |
445,205 |
63% |
460,293 |
65% |
121,764 |
17% |
132,358 |
19% |
139,784 |
20% |
| DM patients |
111,684 |
89,344 |
80% |
92,185 |
83% |
93,952 |
84% |
74,576 |
67% |
78,598 |
70% |
81,104 |
73% |
76,413 |
68% |
79,932 |
72% |
81,965 |
73% |
| RA patients | 4,523 | 3,676 | 81% | 3,774 | 83% | 3,840 | 85% | 2,650 | 59% | 2,813 | 62% | 2,915 | 64% | 839 | 19% | 918 | 20% | 984 | 22% |
* All tests = any of a set of 23 different frequently-performed laboratory tests recorded in study database.